Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children

• Status: Terminated
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Levobupivacaïne (Chirocaine®) is a new local anaesthetic recently marketed in France. The goal of this prospective work is to study the pharmacokinetic aspect of this drug after injection around the sciatic nerve (subgluteal way).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assistance Publique Hopitaux De Marseille
• Treatments: Bupivacaine; Levobupivacaine

Criteria

Inclusion Criteria:

• Surgical pathology of the leg or the foot with garot tyre of thigh

• Age included between 6 months and 12 years

• Status ASA I or II

Exclusion Criteria:

• Bilateral or one-sided surgical gesture realized without garot tyre

• Cutaneous infection in the point of draining

• Clinical confusion of the coagulation

• Allergy informed in the local anesthesics of amino-acid class

• Evolutionary neurological pathology of the operated limb

• Renal, respiratory, cardiac or hepatic insufficiency.